학술논문
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort
Document Type
Article
Author
Emiloju, O.E.; Hendrickson, A.E.W.; Kaufmann, S.H.; Hubbard, J.M.; Costello, B.A.; Yin, J.; Koubek, E.; Reid, J.M.; Borad, M.J.; Seetharam, M.; Lou, Y.; Edelman, M.J.; Sausville, E.A.; Jiang, Y.; Kaseb, A.O.; Posey, J.A.; Davis, S.L.; Gores, G.J.; Roberts, L.R.; Takebe, N.; Schwartz, G.K.; Adjei, A.A.
Source
In: Investigational New Drugs . (Investigational New Drugs, February 2024, 42(1):127-135)
Subject
Language
English
ISSN
15730646
01676997
01676997